Developer docs
API playgroundTry for free, no card

Search company profiles

Brightseed

Full company profile

uuid00003dz

Namestring
Brightseed
Legal namestring
Brightseed, Inc.
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Brightseed is a bio- and AI-native innovation platform for health and life sciences companies, founded in 2017 and headquartered in South San Francisco. The company's Forager engine maps natural compounds to biological mechanisms and health pathways using a proprietary dataset that has expanded from 11 million to 21 million bioactives across 23 health territories, supported by over seven years of experimentally validated data. Hummingbird, launched in May 2026, extends the platform from discovery into development as an agentic AI product that accepts natural-language queries and returns actionable product evaluations in seconds. Both products are positioned as the world's first clinically-validated, continuous enterprise AI platform for health sciences innovation.

Brightseed operates a B2B platform-first subscription model targeting enterprise R&D and product development teams in consumer health, nutrition, pharmaceuticals, animal health, and cosmetics. The company serves more than 40 named industry partners including Danone, Haleon, L'Oréal, Nestlé Health Science, Ocean Spray, Opella, and Kallyope. Revenue streams include platform subscriptions (with a three-tier model covering subscriptions, data generation, and expert services), optional onboarding and enablement services, and B2B sales of proprietary clinically-validated ingredient products Bio Gut Core (digestive health) and BioMetaControl (metabolic health, positioned as a GLP-1 companion). Pricing is not publicly disclosed; contracts are sold on annual billing cycles via direct enterprise field sales.

The company has raised approximately $120.8 million in disclosed funding across six rounds between 2018 and 2023, with a $68 million round in May 2022 led by Temasek alongside AgFunder, S2G Investments, Continental Grain Company, Germin8 Ventures, and Lewis & Clark AgriFood. Brightseed is led by co-founder and CEO Jim Flatt, co-founder/CSO/CTO Lee Chae, and co-founder/Chairman Sofia Elizondo, with a headcount of 51-100 employees. Customers retain ownership of discoveries, ingredients, and IP developed using the platform, while Brightseed retains platform IP and commercializes its own ingredient portfolio.

Short descriptiontext

Brightseed is a South San Francisco-based AI platform that maps natural compounds to biological mechanisms, helping health and life sciences companies discover, validate, and commercialize new ingredients. Its Forager engine and Hummingbird agentic AI serve 40+ enterprise partners across nutrition, pharma, and consumer health.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI bioactive discovery, nutraceutical innovation platform, health sciences AI, bioactive ingredient development, enterprise life sciences software
Industry3 codes
PRIMARYEUAAAIAK
Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYCRADAGAM
Healthy Aging & Cognitive Support Supplements
SECONDARYHLAIAAAE
Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code3 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Medicinal and Botanical Manufacturing325411
  • Scientific Research and Development Services5417
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
AI Bioactive Discovery Platform
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Platform Subscriptions
TypeSubscription Recurring
Description

Brightseed operates as a platform-first subscription business transitioning customers to recurring subscription model. The platform provides software-as-a-service (SaaS) and data-as-a-service to global health science clients.

brightseedbio.com
2Three-Tier Pricing Model
TypeSubscription Recurring
Description

Hummingbird product offered under three-tier pricing model covering subscriptions, data generation, and expert services. Optional services for onboarding and enablement are also available.

agfundernews.com
3Ingredient Sales
TypeOne Time License
Description

While primarily a platform company, Brightseed has commercialized two novel bioactives (NCT and NFT) in BioMetaControl supplement marketed as GLP-1 companion for metabolic health. The company engages in B2B sales of these specific ingredients.

businesswire.com
4Professional Services
TypeProfessional Services
Description

Optional services for onboarding and enablement complement the core platform subscription offering.

brightseedbio.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Three-tier pricing model including subscriptions, data generation, and expert services
ModelSubscriptionBilling cadenceAnnual
Notes

Specific tier pricing not publicly disclosed

agfundernews.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 4 records shown
1Forager™
Description

AI-powered biological discovery engine built on proprietary bioactive dataset spanning more than 11 million compounds across 23 health areas.

brightseedbio.com
+3 more records
Core offering1 text field

Brightseed operates a continuous, clinically-validated AI-powered health sciences innovation platform that combines the Forager™ AI discovery engine (mapping more than 11 million proprietary bioactives to biological mechanisms across 23 health territories) with the Hummingbird™ agentic AI product for development decision-making. The company sells platform subscriptions and data services to enterprise R&D teams in consumer health, nutrition, pharmaceuticals, animal health, and cosmetics, and also commercializes clinically-validated bioactive ingredients such as Bio Gut Core™, BioMetaControl™, and Bio Gut Fiber™.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • A PhD scientist achieved in two weeks using Hummingbird what previously took six months
+5 more records
Product overview1 text field

Brightseed operates as a continuous innovation platform combining deep science, cutting-edge AI, and proprietary bioactive data to transform how health science teams discover, validate, and commercialize new products. The platform follows a platform-plus-modules architecture anchored by Forager™ (AI-powered biological discovery engine with 11+ million bioactives across 23 health territories) extended by Hummingbird™ (agentic AI for development decision-making), supported by an Enterprise AI Platform integrating discovery, development, and commercialization. The portfolio includes commercialized bioactive ingredient products—Bio Gut Core™ for digestive health and BioMetaControl™ as a GLP-1 companion for metabolic health—alongside discovery tools (Bioactive Ingredient Finder, Bioactive Profiler) and Science-Backed Plant-Based Bioactives services. Brightseed serves B2B customers (innovation leaders, R&D teams, product development organizations) with software-as-a-service and data-as-a-service offerings under a recurring subscription model. Customers retain ownership of discoveries, ingredients, and IP developed using the platform.

Product and service6 records
1Forager™ Platform
CategoryAI Bioactive Discovery Platform
Description

AI-powered biological discovery engine built on more than 11 million proprietary bioactives and hundreds of biological receptors across 23 health areas. Maps natural compounds to biological mechanisms and health pathways for enterprise customers in nutrition, wellness, agriculture, and pharmaceutical applications.

2Hummingbird™
CategoryAgentic AI Development Platform
Description

Agentic AI product built on the Forager platform that enables nutrition and health companies to query natural compound data using natural language and receive answers in seconds. Helps teams evaluate, prioritize, and advance product opportunities ahead of major development investment.

3Enterprise AI Platform
CategoryEnterprise AI Innovation Platform
Description

Continuous AI-powered health sciences innovation platform integrating discovery, development, and commercialization, built on proprietary bioactive datasets spanning more than 11 million natural compounds across 23 health territories and over seven years of experimentally validated data.

4Bio Gut Core™
CategoryBioactive Ingredient Product
Description

Low-dose digestive health ingredient clinically proven to strengthen gut barrier function and reduce bloating and abdominal pain in three weeks. Developed using AI discovery from compounds found in plants like garlic and black pepper.

5BioMetaControl™
CategoryBioactive Ingredient Product
Description

Nature-inspired GLP-1 companion ingredient for metabolic health containing clinically validated bioactives NCT (N-trans caffeoyltyramine) and NFT (N-trans feruloyltyramine). Demonstrated statistically significant improvements in glycemic control in adults with prediabetes in a peer-reviewed clinical trial.

6Bio Gut Fiber™
Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-03-01
Description

Evra Ingredients partnered with Brightseed to unlock next-generation natural ingredients with AI-powered discovery.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-04-30
Description

Brightseed and Haleon announced strategic collaboration to harness AI for small molecule discovery and human health innovation. The partnership focuses on using Brightseed's Forager AI platform to discover novel bioactive compounds for health applications.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-09-17
Description

Brightseed and Botalys partnered to cultivate sustainably sourced bioactive botanicals for beauty, health and wellness sectors using AI-powered discovery.

4Ocean Spray
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-06-26
Description

Ocean Spray and Brightseed expanded their partnership to validate novel health benefits of bioactive compounds found in various cranberry varieties using Forager AI. The partnership began in 2021 and continues to leverage AI to decode and validate the total health potential of cranberries for consumer nutrition applications. AI analysis predicted four times more phytonutrients related to human health including terpenes in cognition and immunity areas.

globenewswire.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Danone is listed as a strategic partner collaborating with Brightseed on bioactive discovery and health science innovation initiatives.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Kallyope is listed as a strategic partner in Brightseed's ecosystem for bioactive discovery.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

L'Oréal is listed as a strategic partner collaborating with Brightseed on bioactive discovery for beauty and wellness applications.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Nestlé Health Science is listed as a strategic partner in Brightseed's innovation ecosystem.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

NutriQuest is listed as a strategic partner in Brightseed's bioactive discovery ecosystem.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Opella is listed as a strategic partner in Brightseed's ecosystem for health science innovation.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Pharamvite is listed as a strategic partner in Brightseed's innovation platform ecosystem.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Research partnership where Brightseed's AI was used as a case study to identify over 500 compounds in almonds, with 400 previously undiscovered, demonstrating AI's potential in food science compound discovery.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

AI company focused on small molecule drug design using structure-based deep learning. Comparable AI-first discovery platform targeting pharma partners; less focused than Brightseed on nutrition and consumer health bioactives.

TypeBroad incumbent
Description

Computational chemistry and molecular simulation platform serving pharma, biotech, and materials science. Broad incumbent that, like Brightseed, sells subscription-based scientific software to enterprise R&D teams, but operates across a wider portfolio of industries.

TypeRegional player
Description

Belgium-based producer of sustainably cultivated premium botanical ingredients for health, beauty, and wellness brands. Already a Brightseed partnership counterparty, Botalys sits one layer upstream as a vertically specialized supplier rather than a discovery platform competitor.

TypeEmerging player
Description

AI-driven food technology company using proprietary models (Giuseppe AI) to formulate plant-based food and ingredient alternatives. Comparable in applying AI to discover and reformulate natural compounds for consumer CPG, but focused on plant-based foods rather than broad bioactives.

5Culture Biosciences
TypeOthers
Description

Cloud biomanufacturing platform enabling CPG and synthetic biology companies to run fermentation and bioprocess R&D at scale. Ecosystem adjacent to Brightseed's bioactives value chain — supports the development and scale-up of bioactives that Brightseed discovers.

TypeEmerging player
Description

AI-for-biotech company that combines multimodal patient data with machine learning to accelerate drug discovery and development. Adjacent emerging player serving life sciences R&D with AI-driven intelligence, though anchored in clinical data rather than bioactives.

TypeDirect peer
Description

AI-native drug discovery company combining generative chemistry, biology, and clinical validation. Comparable to Brightseed's enterprise AI-for-bioactives model, though focused on small-molecule pharma rather than nutrition and consumer health.

TypeDirect peer
Description

AI-driven drug discovery company combining high-throughput biology with machine learning. Directly comparable in using proprietary biological datasets and ML to accelerate discovery and reduce late-stage failures in life sciences.

TypeDirect peer
Description

AI- and quantum physics-driven drug discovery and molecular simulation platform serving global pharma. Direct peer in AI-native scientific platforms for life sciences enterprise customers.

TypeDirect peer
Description

AI-driven discovery platform for bioactive peptides in food, nutrition, and personal care. Closest direct peer to Brightseed: applies machine learning to natural compound libraries to identify health-benefiting peptides for CPG and supplement brands.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors13 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Brightseed

AI Bioactive Discovery Platformbrightseedbio.com

Brightseed is a South San Francisco-based AI platform that maps natural compounds to biological mechanisms, helping health and life sciences companies discover, validate, and commercialize new ingredients. Its Forager engine and Hummingbird agentic AI serve 40+ enterprise partners across nutrition, pharma, and consumer health.

What Brightseed does

Brightseed is a bio- and AI-native innovation platform for health and life sciences companies, founded in 2017 and headquartered in South San Francisco. The company's Forager engine maps natural compounds to biological mechanisms and health pathways using a proprietary dataset that has expanded from 11 million to 21 million bioactives across 23 health territories, supported by over seven years of experimentally validated data. Hummingbird, launched in May 2026, extends the platform from discovery into development as an agentic AI product that accepts natural-language queries and returns actionable product evaluations in seconds. Both products are positioned as the world's first clinically-validated, continuous enterprise AI platform for health sciences innovation.

Brightseed operates a B2B platform-first subscription model targeting enterprise R&D and product development teams in consumer health, nutrition, pharmaceuticals, animal health, and cosmetics. The company serves more than 40 named industry partners including Danone, Haleon, L'Oréal, Nestlé Health Science, Ocean Spray, Opella, and Kallyope. Revenue streams include platform subscriptions (with a three-tier model covering subscriptions, data generation, and expert services), optional onboarding and enablement services, and B2B sales of proprietary clinically-validated ingredient products Bio Gut Core (digestive health) and BioMetaControl (metabolic health, positioned as a GLP-1 companion). Pricing is not publicly disclosed; contracts are sold on annual billing cycles via direct enterprise field sales.

The company has raised approximately $120.8 million in disclosed funding across six rounds between 2018 and 2023, with a $68 million round in May 2022 led by Temasek alongside AgFunder, S2G Investments, Continental Grain Company, Germin8 Ventures, and Lewis & Clark AgriFood. Brightseed is led by co-founder and CEO Jim Flatt, co-founder/CSO/CTO Lee Chae, and co-founder/Chairman Sofia Elizondo, with a headcount of 51-100 employees. Customers retain ownership of discoveries, ingredients, and IP developed using the platform, while Brightseed retains platform IP and commercializes its own ingredient portfolio.

Brightseed firmographics

Firmographics
Name
Brightseed
Legal name
Brightseed, Inc.
Website
https://brightseedbio.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Brightseed is a South San Francisco-based AI platform that maps natural compounds to biological mechanisms, helping health and life sciences companies discover, validate, and commercialize new ingredients. Its Forager engine and Hummingbird agentic AI serve 40+ enterprise partners across nutrition, pharma, and consumer health.
Ownership category
akta.pro rank

Brightseed industry classification

Industry
Product category
AI Bioactive Discovery Platform
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medicinal and Botanical Manufacturing (325411), Scientific Research and Development Services (5417)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYEUAAAIAK
Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYCRADAGAM
Healthy Aging & Cognitive Support Supplements
SECONDARYHLAIAAAE
Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • AI bioactive discovery
  • Nutraceutical innovation platform
  • Health sciences AI
  • Bioactive ingredient development
  • Enterprise life sciences software

Where Brightseed is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Brightseed business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Platform Subscriptions: Brightseed operates as a platform-first subscription business transitioning customers to recurring subscription model. The platform provides software-as-a-service (SaaS) and data-as-a-service to global health science clients.
  2. Three-Tier Pricing Model: Hummingbird product offered under three-tier pricing model covering subscriptions, data generation, and expert services. Optional services for onboarding and enablement are also available.
  3. Ingredient Sales: While primarily a platform company, Brightseed has commercialized two novel bioactives (NCT and NFT) in BioMetaControl supplement marketed as GLP-1 companion for metabolic health. The company engages in B2B sales of these specific ingredients.
  4. Professional Services: Optional services for onboarding and enablement complement the core platform subscription offering.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualThree-tier pricing model including subscriptions, data generation, and expert services

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Brightseed product offering

Product offering

Core offering

Brightseed operates a continuous, clinically-validated AI-powered health sciences innovation platform that combines the Forager™ AI discovery engine (mapping more than 11 million proprietary bioactives to biological mechanisms across 23 health territories) with the Hummingbird™ agentic AI product for development decision-making. The company sells platform subscriptions and data services to enterprise R&D teams in consumer health, nutrition, pharmaceuticals, animal health, and cosmetics, and also commercializes clinically-validated bioactive ingredients such as Bio Gut Core™, BioMetaControl™, and Bio Gut Fiber™.

Product overview

Brightseed operates as a continuous innovation platform combining deep science, cutting-edge AI, and proprietary bioactive data to transform how health science teams discover, validate, and commercialize new products. The platform follows a platform-plus-modules architecture anchored by Forager™ (AI-powered biological discovery engine with 11+ million bioactives across 23 health territories) extended by Hummingbird™ (agentic AI for development decision-making), supported by an Enterprise AI Platform integrating discovery, development, and commercialization. The portfolio includes commercialized bioactive ingredient products—Bio Gut Core™ for digestive health and BioMetaControl™ as a GLP-1 companion for metabolic health—alongside discovery tools (Bioactive Ingredient Finder, Bioactive Profiler) and Science-Backed Plant-Based Bioactives services. Brightseed serves B2B customers (innovation leaders, R&D teams, product development organizations) with software-as-a-service and data-as-a-service offerings under a recurring subscription model. Customers retain ownership of discoveries, ingredients, and IP developed using the platform.

Differentiator

Problem solved

Functional benefit

Brands

  • Forager™: AI-powered biological discovery engine built on proprietary bioactive dataset spanning more than 11 million compounds across 23 health areas.
  • Hummingbird™
  • Bio Gut Core™
  • BioMetaControl™

Products and services

  • Forager™ Platform AI-powered biological discovery engine built on more than 11 million proprietary bioactives and hundreds of biological receptors across 23 health areas. Maps natural compounds to biological mechanisms and health pathways for enterprise customers in nutrition, wellness, agriculture, and pharmaceutical applications.
  • Hummingbird™ Agentic AI product built on the Forager platform that enables nutrition and health companies to query natural compound data using natural language and receive answers in seconds. Helps teams evaluate, prioritize, and advance product opportunities ahead of major development investment.
  • Enterprise AI Platform Continuous AI-powered health sciences innovation platform integrating discovery, development, and commercialization, built on proprietary bioactive datasets spanning more than 11 million natural compounds across 23 health territories and over seven years of experimentally validated data.
  • Bio Gut Core™ Low-dose digestive health ingredient clinically proven to strengthen gut barrier function and reduce bloating and abdominal pain in three weeks. Developed using AI discovery from compounds found in plants like garlic and black pepper.
  • BioMetaControl™ Nature-inspired GLP-1 companion ingredient for metabolic health containing clinically validated bioactives NCT (N-trans caffeoyltyramine) and NFT (N-trans feruloyltyramine). Demonstrated statistically significant improvements in glycemic control in adults with prediabetes in a peer-reviewed clinical trial.
  • Bio Gut Fiber™

Quantifiable outcome

  • A PhD scientist achieved in two weeks using Hummingbird what previously took six months
  • +5 more outcomes

Companies that use Brightseed

Customer profile

Named customers10 records

Segments5 records

Ideal customer profiles3 records

Brightseed technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature5 records

Brightseed partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered minor and core.

  • Evra IngredientsminorStrategic or Co-development Partner · 1 March 2026Evra Ingredients partnered with Brightseed to unlock next-generation natural ingredients with AI-powered discovery.
  • HaleoncoreStrategic or Co-development Partner · 30 April 2025Brightseed and Haleon announced strategic collaboration to harness AI for small molecule discovery and human health innovation. The partnership focuses on using Brightseed's Forager AI platform to discover novel bioactive compounds for health applications.
  • BotalysminorStrategic or Co-development Partner · 17 September 2024Brightseed and Botalys partnered to cultivate sustainably sourced bioactive botanicals for beauty, health and wellness sectors using AI-powered discovery.
  • Ocean SpraycoreStrategic or Co-development Partner · 26 June 2024Ocean Spray and Brightseed expanded their partnership to validate novel health benefits of bioactive compounds found in various cranberry varieties using Forager AI. The partnership began in 2021 and continues to leverage AI to decode and validate the total health potential of cranberries for consumer nutrition applications. AI analysis predicted four times more phytonutrients related to human health including terpenes in cognition and immunity areas.
  • DanonecoreStrategic or Co-development PartnerDanone is listed as a strategic partner collaborating with Brightseed on bioactive discovery and health science innovation initiatives.
  • KallyopeminorStrategic or Co-development PartnerKallyope is listed as a strategic partner in Brightseed's ecosystem for bioactive discovery.
  • L'OréalcoreStrategic or Co-development PartnerL'Oréal is listed as a strategic partner collaborating with Brightseed on bioactive discovery for beauty and wellness applications.
  • Nestlé Health SciencecoreStrategic or Co-development PartnerNestlé Health Science is listed as a strategic partner in Brightseed's innovation ecosystem.
  • NutriQuestminorStrategic or Co-development PartnerNutriQuest is listed as a strategic partner in Brightseed's bioactive discovery ecosystem.
  • OpellaminorStrategic or Co-development PartnerOpella is listed as a strategic partner in Brightseed's ecosystem for health science innovation.
  • PharamviteminorStrategic or Co-development PartnerPharamvite is listed as a strategic partner in Brightseed's innovation platform ecosystem.
  • Almond Board of CaliforniaminorStrategic or Co-development PartnerResearch partnership where Brightseed's AI was used as a case study to identify over 500 compounds in almonds, with 400 previously undiscovered, demonstrating AI's potential in food science compound discovery.

Scale indicators10 records

Recent moves6 records

Expansion highlights7 records

Brightseed competitors and assessment

Company assessment

Direct peers

  • Atomwise: AI company focused on small molecule drug design using structure-based deep learning. Comparable AI-first discovery platform targeting pharma partners; less focused than Brightseed on nutrition and consumer health bioactives.
  • Insilico Medicine: AI-native drug discovery company combining generative chemistry, biology, and clinical validation. Comparable to Brightseed's enterprise AI-for-bioactives model, though focused on small-molecule pharma rather than nutrition and consumer health.
  • Recursion Pharmaceuticals: AI-driven drug discovery company combining high-throughput biology with machine learning. Directly comparable in using proprietary biological datasets and ML to accelerate discovery and reduce late-stage failures in life sciences.
  • XtalPi: AI- and quantum physics-driven drug discovery and molecular simulation platform serving global pharma. Direct peer in AI-native scientific platforms for life sciences enterprise customers.
  • Nuritas: AI-driven discovery platform for bioactive peptides in food, nutrition, and personal care. Closest direct peer to Brightseed: applies machine learning to natural compound libraries to identify health-benefiting peptides for CPG and supplement brands.

Broad incumbents

  • Schrödinger: Computational chemistry and molecular simulation platform serving pharma, biotech, and materials science. Broad incumbent that, like Brightseed, sells subscription-based scientific software to enterprise R&D teams, but operates across a wider portfolio of industries.

Regional players

  • Botalys: Belgium-based producer of sustainably cultivated premium botanical ingredients for health, beauty, and wellness brands. Already a Brightseed partnership counterparty, Botalys sits one layer upstream as a vertically specialized supplier rather than a discovery platform competitor.

Emerging players

  • NotCo: AI-driven food technology company using proprietary models (Giuseppe AI) to formulate plant-based food and ingredient alternatives. Comparable in applying AI to discover and reformulate natural compounds for consumer CPG, but focused on plant-based foods rather than broad bioactives.
  • Owkin: AI-for-biotech company that combines multimodal patient data with machine learning to accelerate drug discovery and development. Adjacent emerging player serving life sciences R&D with AI-driven intelligence, though anchored in clinical data rather than bioactives.

Others

  • Culture Biosciences: Cloud biomanufacturing platform enabling CPG and synthetic biology companies to run fermentation and bioprocess R&D at scale. Ecosystem adjacent to Brightseed's bioactives value chain — supports the development and scale-up of bioactives that Brightseed discovers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Brightseed social profiles

Digital presence

Brightseed financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Brightseed leadership team

Management profile

Number of profiles

Profiles3 records

Brightseed funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors13 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Brightseed M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Brightseed

What does Brightseed do?

Brightseed operates a continuous, clinically-validated AI-powered health sciences innovation platform that combines the Forager™ AI discovery engine (mapping more than 11 million proprietary bioactives to biological mechanisms across 23 health territories) with the Hummingbird™ agentic AI product for development decision-making. The company sells platform subscriptions and data services to enterprise R&D teams in consumer health, nutrition, pharmaceuticals, animal health, and cosmetics, and also commercializes clinically-validated bioactive ingredients such as Bio Gut Core™, BioMetaControl™, and Bio Gut Fiber™.

Is Brightseed a public or private company?

Brightseed is a private company. It is classified as venture growth investor backed and is currently operating.

When was Brightseed founded?

Brightseed was founded in 2017. It employs 11 to 50 people.

Where is Brightseed based?

Brightseed is headquartered in San Francisco, United States, in the North America region.

How does Brightseed make money?

Four revenue lines are on record. Platform Subscriptions are the primary driver. The others are three-Tier Pricing Model, ingredient Sales and professional Services.

Who are Brightseed's main competitors?

Direct peers on record are Atomwise, Insilico Medicine, Recursion Pharmaceuticals, XtalPi and Nuritas. Schrödinger is listed as a broad incumbent. Botalys is listed as a regional player. Emerging players are NotCo and Owkin. Culture Biosciences is listed as an others.

Does Brightseed have an API?

No public API is recorded for Brightseed.

What industry is Brightseed in?

Brightseed's product category is AI Bioactive Discovery Platform. Its primary akta.pro industry code is EUAAAIAK, Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives, with a secondary code of CRADAGAM, Healthy Aging & Cognitive Support Supplements. Its NAICS code is 541714 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
nutraingredients.com‘Discovery is only the first step’: Brightseed CEO on AI’s next role in nutrition R&DBrightseed, a California-based biotech company, has launched Hummingbird, an agentic AI platform that extends beyond its existing Forager discovery engine to support development-stage decision-making in nutrition R&D. The platform, built on Brightseed's proprietary dataset of 21 million bioactive compounds, helps teams evaluate biological relevance, assess risks earlier, and prioritize concepts for commercialization. CEO Lee Chae emphasized that the goal is to shift innovation from fragmented trial-and-error processes into evidence-driven capabilities that increase the probability of commercially viable outcomes.NewsweekAgri-Tech’s Climate Revolution Is Securing Our Wellness FutureThe wellness industry, valued at approximately $2 billion in 2025, is increasingly dependent on AI-enabled agriculture to source ingredients amid climate challenges affecting traditional farming. AI tools including precision agriculture, crop disease detection systems, and machine learning algorithms are helping growers optimize yields, predict phytochemical content, and improve sustainability for fragile medicinal plants and bioactive ingredients. Companies including NotCo AI and Brightseed are leveraging AI platforms to help cosmetic and wellness brands develop optimized ingredient sourcing and production systems for the wellness supply chain.TrendHunter.comBioactive AI Discovery PlatformsBrightseed announced the expansion of its AI-powered natural compound dataset to 21 million compounds, strengthening its platform for discovering bioactive molecules across nutrition, wellness, agriculture, and pharmaceutical applications. The platform maps compounds to biological mechanisms and health pathways, enabling researchers and commercial partners to accelerate product development while reducing the cost and time associated with traditional discovery methods. The growth of AI-powered biological research reflects increasing demand for scalable discovery systems across healthcare and consumer wellness industries.AgFunderNewsBrightseed layers agentic AI onto Forager bioactives discovery platform with Hummingbird launchBrightseed has launched Hummingbird, an agentic AI product built on its Forager bioactives discovery platform that enables nutrition and health companies to query natural compound data using natural language and receive answers in seconds rather than days or weeks. One customer reported that a PhD scientist achieved in two weeks using Hummingbird what previously took six months. Brightseed has onboarded two customers since February and is contracting with additional customers, with plans to release new agents quarterly under a three-tier pricing model covering subscriptions, data generation, and expert services.Business Wire BlogBrightseed Launches Hummingbird™, Advancing Its AI-Powered Innovation Platform from Discovery to DevelopmentBrightseed, Inc., a bio- and AI-powered innovation platform for life science teams based in South San Francisco, California, announced the launch of Hummingbird, an agentic AI product designed to help teams turn biological discovery into higher-confidence development decisions and commercially viable product opportunities. The new product extends Brightseed's platform beyond discovery into development by building on the company's proprietary bioactive dataset and seven years of experimentally validated data to help reduce costly late-stage failures. The launch positions Brightseed as a continuous AI-powered platform for life sciences innovation, connecting discovery and development stages that were previously fragmented.FinancialContent Business PageBrightseed Launches Hummingbird™, Advancing Its AI-Powered Innovation Platform from Discovery to DevelopmentBrightseed, Inc., a bio- and AI-native innovation platform for life sciences, announced the launch of Hummingbird™, an agentic AI product designed to help teams evaluate, prioritize, and advance product opportunities ahead of major development investment. The platform extends Brightseed's capabilities from discovery into development, building on one of the world's largest proprietary bioactive datasets and the Forager™ discovery engine to reduce late-stage failure and improve decision confidence. The launch reinforces Brightseed's position as a category-defining AI-powered platform company, backed by over 40 industry partners, combining proprietary data, scientific expertise, and agentic AI to transform life sciences innovation.EIN PresswireAlmond Market Size to Reach USD 14.11 Billion by 2032 at 4.5% CAGR | Maximize Market ResearchThe global almond market is projected to grow from USD 10.37 billion in 2025 to USD 14.11 billion by 2032 at a 4.5% CAGR. Asia-Pacific leads growth at 7.8% CAGR, driven by India's 74% shipment surge and Middle East's 41% export growth. Blue Diamond Growers holds 10.2% market share in 2025.GreyBPrecision Nutrition Innovations 2026: Digitally Advanced with AIThis industry trend report covers five emerging innovations in precision nutrition—NutriDiary (a mobile app for digitized dietary tracking), MealMeter (a wearable-based macronutrient estimation system developed at Arizona State University), Pinkmatter (a 2024-founded startup offering personalized PMS supplements targeting gut microbiome), BrightSeed's Forager AI platform (a bioactive discovery tool partnered with companies like Haleon and Danone), and Better & Better Co.'s smart supplement delivery system integrated into everyday products. The report highlights how AI, machine learning, microbiome science, and multimodal sensing are making personalized nutrition more scalable and cost-effective, while noting that regulatory complexity across HIPAA, GDPR, and FDA frameworks remains a key challenge for the sector.Business Wire BlogBrightseed Launches the World’s First Clinically-Validated, Enterprise AI Platform, Built on Over a Decade of Scientific ResearchBrightseed, Inc., a South San Francisco-based AI life sciences company, announced the launch of what it claims is the world's first continuous, AI-powered health sciences innovation platform, designed to increase the probability of commercial success across the health and life sciences industry. The platform, called Forager, is built on the company's proprietary bioactive dataset spanning more than 11 million natural compounds across 23 health territories, with the goal of addressing the industry problem where over 75% of early product ideas fail to reach market. The company is transitioning to a recurring subscription model and currently serves the $6.8 trillion global wellness market with over 40 industry partnerships across consumer health, nutrition, pharmaceuticals, and animal health sectors.FinancialContent Business PageBrightseed Launches the World’s First Clinically-Validated, Enterprise AI Platform, Built on Over a Decade of Scientific ResearchBrightseed, Inc. announced the launch of what it claims is the world's first continuous AI-powered health sciences innovation platform, designed to increase the probability of commercial success across health and life sciences. The platform, built on over a decade of scientific research, features the Forager AI discovery engine trained on more than 11 million natural compounds across 23 health territories, and is transitioning customers to a recurring subscription model. The company, backed by more than 40 industry partnerships, is evolving from a discovery-focused bioactives company into a platform-based enterprise AI company serving the global wellness market.